Japan National Cancer Center Starts Clinical Trials With Biliary Tract Drug
This article was originally published in PharmAsia News
The National Cancer Research Center will start a clinical study regarding the development of a molecular target drug for biliary tract cancer, it was announced on June 6.
You may also be interested in...
Angelini is looking to take its recently-acquired ThermaCare brand to the next level by establishing a direct base in Germany to market the product and through a new distribution deal with Norway's Navamedic.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.
Experts think GLP-1s in neurodegeneration may be Novo Nordisk’s next opportunity and await readouts from the Phase II ELAD trial in Alzheimer's disease for signals.